Tectonic Therapeutic Inc. (TECX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tectonic Therapeutic Inc. (TECX:NASDAQ), powered by AI.

Current Price
$30.01
Sector
Healthcare
What is the Tectonic Therapeutic Inc. stock price forecast?

Tectonic Therapeutic Inc. is currently trading at $30.01. View real-time AI analysis on Alpha Lenz.

What is Tectonic Therapeutic Inc. insider trading activity?

View the latest insider trading data for Tectonic Therapeutic Inc. on Alpha Lenz.

What is Tectonic Therapeutic Inc.'s P/E ratio?

View Tectonic Therapeutic Inc.'s valuation metrics on Alpha Lenz.

Tectonic Therapeutic Inc.

NASDAQ · TECX
$30.01+0.62(+2.11%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Tectonic Therapeutic Inc.'s future dividend policy...
Alpha Chat Insight

Tectonic Therapeutic Inc.'s ROE is -37.8%. Explore profitability and growth together.

Ask for details

Company Overview

Tectonic Therapeutic Inc. is a biopharmaceutical company focused on the discovery and development of transformative therapies. The primary aim of Tectonic Therapeutic is to create innovative treatments that target unmet medical needs, particularly in the realm of complex diseases. The company utilizes advanced technology platforms to identify and develop novel drugs, emphasizing precision medicine. This approach allows for the creation of tailored therapies that improve efficacy while minimizing side effects. Tectonic Therapeutic is highly influential in the biotechnology and healthcare sectors, where it collaborates with research institutions and industry partners to accelerate the development of its therapeutic programs. By focusing on cutting-edge research and leveraging proprietary techniques, the company plays a crucial role in advancing the landscape of medical treatment, contributing to improved patient outcomes and offering new hope for conditions previously deemed untreatable. In the financial markets, Tectonic Therapeutic is recognized for its potential to significantly impact the health and biotech industries, driven by its commitment to innovation and science-driven solutions. Its activities are closely watched by stakeholders and investors interested in the evolving field of medical biotechnology.

CEODr. Alise S. Reicin M.D., Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees51

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
51Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-35.83%ROA
-37.82%ROE
-35.20%ROIC

Financial Health

$253.80MCash & Cash Equivalents
$-244.09MNet Debt
3.86%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tectonic Therapeutic Inc. (ticker: TECX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 51 employees.

The current price is $30.01 with a P/E ratio of -x and P/B of -x.

ROE is -37.82%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tectonic Therapeutic Inc. (TECX) Stock Forecast 2026 $30.01 — Price, Financials & Analyst Targets | Alpha Lenz